Abstract
There is an urgent need to improve the broad molecular profiling of advanced non-squamous non-small cell lung carcinoma (NS-NSCLC) patients, notably for a rapid assessment of multiple genomic alterations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
